VANECK ETF TRUST - PHARMACEUTCL ETF (PPH)

Historical Portfolio Holders from Q1 2016 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / PHARMACEUTCL ETF
Shares, excl. options Q1 2024
4.36 M
Holdings value Q1 2024
$395 M
Value change Q1 2024
-$1.8 M
Grand Portfolio weight change Q1 2024
0%
Number of holders
126
Number of buys Q1 2024
66
Number of sells Q1 2024
-38
Average buys Q1 2024 %
+0.001%
Average sells Q1 2024 %
0%
CUSIP
92189F692
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 4.36 M $395 M -$1.8 M $90.70 126
2023 Q4 4.5 M $366 M -$15.4 M $81.37 103
2023 Q3 4.66 M $372 M +$18.2 M $79.86 95
2023 Q2 4.52 M $356 M +$6.16 M $78.77 95
2023 Q1 4.45 M $345 M -$178 M $77.63 100
2022 Q4 6.45 M $501 M +$29.8 M $77.74 105
2022 Q3 6.21 M $419 M +$120 M $67.24 81
2022 Q2 4.42 M $339 M +$272 M $76.84 85
2022 Q1 873 K $69.8 M +$8.99 M $79.76 68
2021 Q4 764 K $58.8 M -$6.58 M $76.95 60
2021 Q3 775 K $56.4 M +$3.05 M $72.81 49
2021 Q2 861 K $62.9 M -$122 M $73.07 51
2021 Q1 2.52 M $174 M +$79.8 M $69.02 51
2020 Q4 1.39 M $92.7 M -$36.8 M $66.48 51
2020 Q3 1.95 M $121 M +$27 M $62.16 48
2020 Q2 1.52 M $94.4 M +$34.8 M $62.25 45
2020 Q1 956 K $52 M -$79.3 M $54.39 40
2019 Q4 2.2 M $141 M +$11 M $64.18 47
2019 Q3 1.87 M $106 M +$52 M $56.95 41
2019 Q2 952 K $55.8 M -$3.05 M $58.67 40
2019 Q1 1 M $60.8 M -$33.9 M $60.70 43
2018 Q4 1.56 M $85.5 M -$19.8 M $54.79 42
2018 Q3 1.9 M $122 M -$19.1 M $64.34 41
2018 Q2 2.21 M $130 M +$13.8 M $59.00 46
2018 Q1 1.98 M $113 M +$23.5 M $56.82 50
2017 Q4 1.57 M $92.9 M -$67.1 M $59.31 48
2017 Q3 2.35 M $136 M +$67.6 M $57.76 45
2017 Q2 1.2 M $70.8 M -$41.2 M $59.06 47
2017 Q1 1.9 M $105 M +$2.25 M $55.14 47
2016 Q4 1.86 M $97.6 M -$64.4 M $52.51 46
2016 Q3 3.07 M $176 M +$40.1 M $57.46 53
2016 Q2 2.31 M $136 M +$135 M $58.62 49
2016 Q1 10.8 K $623 K +$623 K $57.52 2